Volume 95 Issue 41 | p. 17 | Concentrates
Issue Date: October 16, 2017

Pfizer mulls sale of consumer business

Department: Business
Keywords: Pharmaceuticals, Pfizer, OTC

Pfizer is considering selling or spinning off its consumer health care division, one of the world’s biggest makers of over-the-counter drugs. Stock analysts expect the unit, which had sales last year of $3.4 billion, to fetch up to $15 billion. Industry watchers say the potential move comes as Pfizer considers a sizable acquisition to bolster its research-driven drug arm. Merck KGaA put its consumer products business up for sale last month.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment